Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 4, 2004, Pages 261-266

  Trandafir, Cristina C ^a   Nishihashi, Tsuyoshi ^a   Wang, Aimin ^a   Murakami, Shizuka ^a   Ji, Xu ^a   Kurahashi, Kazuyoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

5 lipoxygenase; Cerebral vasospasm; Rat; Subarachnoid haemorrhage; Vasopressin

Indexed keywords

1 ETHYL 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 2 QUINOLONE; ARACHIDONATE 5 LIPOXYGENASE; ARGIPRESSIN; RELCOVAPTAN; VASOPRESSIN;

ANIMAL MODEL; ARTICLE; ATTENUATION; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; IN VITRO STUDY; INFLAMMATION; NONHUMAN; RAT; REDUCTION; SUBARACHNOID HEMORRHAGE;

ANIMALS; ARGININE VASOPRESSIN; BASILAR ARTERY; DISEASE MODELS, ANIMAL; FEMALE; INDOLES; PYRANS; PYRROLIDINES; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 1942441591     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03986.x     Document Type: Article

References (40)

1. Sobey CG, Faraci FM. Subarachnoid haemorrhage: What happens to the cerebral arteries? Clin. Exp. Pharmacol. Physiol. 1998; 25: 867-76.
2. Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. J. Clin. Neurosci. 1994; 1: 19-26.
3. Kassell NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562-72.
4. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol. Ther. 1995; 66: 259-84.
5. Cach R, Durboraw C, Smock T, Albeck D. Microvascular spasm is mediated by vasopressin fibers in the rat hippocampal slice. Brain Res. 1989; 483: 221-5.
6. Delgado TJ, Abdul-Rahman Arbab M, Warberg J, Svendgaard NA. The role of vasopressin in acute cerebral vasospasm. J. Neurosurg. 1988; 68: 266-73.
7. Doczi T, Laszlo FA, Szerdahelyi P, Joo P. Involvement of vasopressin in brain edema formation: Further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage. Neurosurgery 1984; 14: 436-41.
8. 1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 2002; 33: 3033-7.
9. Fernández N, Martínez MA, García-Villalón AL, Monge L, Diéguez G. Cerebral vasoconstriction produced by vasopressin in conscious goats. Role of vasopressin V1 and V2 receptors and nitric oxide. Br. J. Pharmacol. 2001; 132: 1837-44.
10. Garcia-Villalon AL, Garcia JL, Fernandez N, Monge L, Gomez B, Dieguez G. Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide. Br. J. Pharmacol. 1996; 118: 1848-54.
11. Katori E, Ohta T, Nakazato Y, Ito S. Vasopressin-induced contraction in the basilar artery in vitro. Eur. J. Pharmacol. 2001; 416: 113-21.
12. 4. Jpn. J. Pharmacol. 2002; 88 (Suppl.): 267P (Abstract).
13. Tsuji T, Cook DA. Vasoconstrictor mechanism of neuropeptides augmented after endothelial removal in isolated, perfused canine basilar arteries. Neural. Res. 1995; 17: 193-200.
14. Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985; 16: 595-602.
15. Kamezaki T, Yanaka K, Nagase S, Fujita K, Kato N, Nose T. Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2002; 97: 1302-5.
16. Pilitsis JG, Coplin WM, O'Regan MH et al. Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and their potential role in vasospasm: A preliminary observation. J. Neurosurg. 2002; 97: 272-9.
17. Dumont AS, Dumont RJ, Chow MM et al. Cerebral vasospasm after subarachnoid hemorrhage. Putative role of inflammation. Neurosurgery 2003; 53: 123-33.
18. Shimizu T, Watanabe T, Asano T, Seyama Y, Takakura K. Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoid hemorrhage. J. Neurochem. 1988; 51: 1126-31.
19. 1a receptors. J. Clin. Invest. 1993; 92: 224-31.
20. Lászlo FA, Varga C, Dóczi T. Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin. Acta Neurochir. 1995; 133: 122-33.
21. Mather HM, Ang V, Jenkins JS. Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 1981; 44: 216-19.
22. Barreca T, Gandolfo C, Corsini G et al. Evaluation of the secretory pattern of plasma arginine vasopressin in stroke patients. Cerebrovasc. Dis. 2001; 11: 113-18.
23. Liu X, Jin Y, Chen G. Effect of vasopressin on delayed neuronal damage in hippocampus following cerebral ischemia and reperfusion in gerbils. Chin. Med. Sci. J. 1996; 11: 93-6.
24. Onda H, Kasuya H, Takakura K et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 1999; 19: 1279-88.
25. Tran Dinh YR, Jomaa A, Callebert J et al. Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage. Neurosurgery 2001; 48: 626-35.
26. Barbosa MD, Arthur AS, Louis RH et al. The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Neurosurgery 2001; 49: 1205-12.
27. Yokota M, Tani E, Maeda Y, Kokubu K. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm. Stroke 1987; 18: 512-18.
28. Winking M, Heldt RM, Simmet T. Thrombin stimulates activation of the cerebral 5-lipoxygenase pathway during blood-brain cell contact. J. Cereb. Blood Flow Metab. 1996; 16: 737-45.
29. Qu T, Uz T, Manev H. Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol. Aging 2000; 21: 647-52.
30. Baskaya MK, Hu Y, Donaldson D et al. Protective effect of the 5-lipoxygenase inhibitor AA-861 on the cerebral edema after transient ischemia. J. Neurosurg. 1996; 85: 112-16.
31. Uz T, Pesold C, Longone P, Manev H. Aging-associated up-regulation of neuronal 5-lipoxygenase expression: Putative role in neuronal vulnerability. FASEB J. 1998; 12: 439-49.
32. Ohtsuki T, Matsumoto M, Hayashi Y et al. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am. J. Physiol. 1995; 268: H1249-57.
33. Bigby TD. The yin and the yang of 5-lipoxygenase pathway activation. Mol. Pharmacol. 2002; 62: 200-2.
34. 4: Metabolism and signal transduction. Arch. Biochem. Biophys. 2001; 385: 231-41.
35. 2-linked cascade. J. Biol. Chem. 2000; 275: 32 357-62.
36. Bonizzi G, Piette J, Schoonbroodt S et al. Reactive oxygen intermediate-dependent NF-KB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity. Mol. Cell Biol. 1999; 19: 1950-60.
37. McGirt MJ, Parra A, Sheng H et al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002; 33: 2317-23.
38. i responses to angiotensin II in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2003; 284; H1269-76.
39. Lee S, Felts KA, Parry GC, Armacost LM, Cobb RR. Inhibition of 5-lipoxygenase blocks IL-1β-induced vascular adhesion molecule-1 gene expression in human endothelial cells. J. Immunol. 1997; 158: 3401-7.
40. Voelkel NF, Tuder RM, Wade K et al. Inhibition of 5-lipoxygenase- activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J. Clin. Invest. 1996; 97: 2491-8.